Pharma & Biotech

The investment community is closely monitoring Outlook Therapeutics as it navigates a decisive period for its flagship ophthalmic drug. While...

Following a strategic realignment, IntelGenx is now channeling its efforts toward advancing its product pipeline and expanding manufacturing capabilities. The...

Axsome Therapeutics is embarking on a significant commercial and regulatory push. The biopharmaceutical company aims to solidify its position in...

A significant legal challenge has been resolved in favor of Abbott Laboratories. This week, a U.S. federal court issued a...

Investor confidence in Johnson & Johnson is strengthening, fueled by a significant regulatory milestone that adds momentum to the stock's...

Biodexa Pharmaceuticals is laying the groundwork for a pivotal phase in its development, targeting 2026 with a refreshed strategy. The...

Eli Lilly has provided a more definitive timeline for one of its most anticipated pipeline assets. During a presentation at...

The healthcare giant Abbott Laboratories has taken a decisive step toward completing the largest acquisition in its corporate history. To...

ImmunityBio, a biotechnology firm, has unveiled staggering commercial growth for its cancer therapy ANKTIVA. The company's fiscal 2025 performance was...

The rapid adoption of modern weight-loss drugs is triggering a fundamental realignment across the food industry. As pure-play snack manufacturers...